Opening The "Black Box" Of Japanese Medical Device Review - An Interview With Kaye Suzuki
This article was originally published in PharmAsia News
Executive Summary
Europe, United States, Japan: For medical device companies seeking an international market, this is a well-trod path
You may also be interested in...
East To Meet West On Cardiovascular Clinical Trial Design
FDA and Japanese regulatory authorities will meet in January to discuss a project for establishing "global" cardiovascular device clinical studies capable of satisfying approval requirements in both countries
Japan Has Only Itself To Blame For Decline In Device Applications – AdvaMed
The costly and burdensome review process in Japan is responsible for a dramatic decline in device approval applications in recent years, AdvaMed contends in comments to the International Trade Commission
Japan’s ’05 Reforms Will Increase Efficiency, Reflect ’04 Industry Effort
Faster reviews of low-risk medical devices in Japan are on the horizon as the fledgling Pharmaceutical & Medical Devices Agency prepares to implement new review processes, effective April 1